Trial Profile
Treatment of Hypoglycemia With Glucagon Among Patients With Type 1 Diabetes Mellitus
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Glucagon (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms GluST1
- 27 Jul 2015 New trial record
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 09 Jun 2015 Primary endpoint (Maximum plasma glucose response) has been met as per 75th Annual Scientific Sessions of the American Diabetes Association.